Clinical Trial Update: Study of Tenecteplase Versus Alteplase for Thrombolysis (Clot Dissolving) in Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tenecteplase versus alteplase for thrombolysis in acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Activase (alteplase)
• TNKASE (tenecteplase)

Snippet

Sponsor: Lars Thomassen | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED